Current Oncology Reports

Top Research Topics at Current Oncology Reports?

Current Oncology Reports investigates studies in Internal medicine, Oncology, Cancer, Chemotherapy and Disease. It explores research in Internal medicine and the adjacent study of Surgery. In addition to Oncology research, the journal aims to explore topics under Targeted therapy, Randomized controlled trial, Prostate cancer and Immunology.

Immunology research discussed connects with the study of Cancer research. Angiogenesis and Melanoma studies are all carried out as a component of the study in Cancer research presented. Current Oncology Reports holds forums on Cancer that merges themes from other disciplines such as Quality of life and Intensive care medicine.

The journal features research on Radiation therapy in an attempt to reinforce studies in the field of Radiology. Current Oncology Reports explores the study of Immunotherapy to improve our understanding of the broader topic of Immune system.

• Internal medicine (45.51%)
• Oncology (43.09%)
• Cancer (22.73%)

What are the most cited papers published in the journal?

• Epidemiology of Brain Metastases (623 citations)
• Obesity and cancer risk: recent review and evidence. (301 citations)
• The role of C-reactive protein as a prognostic indicator in advanced cancer (249 citations)

Research areas of the most cited articles at Current Oncology Reports:

The most cited publications facilitate discussions on Internal medicine, Oncology, Cancer, Cancer research and Disease. While the most cited papers focused on Internal medicine, they were also able to explore topics like Surgery and Pathology. The most cited articles focus on Oncology but the discussions also offer insight into other areas such as Clinical trial, Chemotherapy, Carcinoma, Melanoma and Breast cancer.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Disease

The previous edition focused in particular on these issues:

Current Oncology Reports mainly tackles studies in Internal medicine, Oncology, Cancer, Clinical trial and Immunotherapy. Current Oncology Reports primarily discusses Internal medicine topics, particularly Disease, Myeloid leukemia, Pembrolizumab, Prostate cancer and Metastasis. The close relationship between Radiation therapy and Systemic therapy is one of the points of interest dissected in Oncology research.

Current Oncology Reports focuses on Cancer but the discussions also offer insight into other areas such as Quality of life (healthcare), Cardiotoxicity, Intensive care medicine, Palliative care and Global health. The studies in Intensive care medicine featured incorporate elements of Psychological intervention, Adverse effect and Randomized controlled trial. Topics in Clinical trial were tackled in line with various other fields like Cancer research and Melanoma.

The most cited articles from the last journal are:

• Clinical and Biological Features of Neuroendocrine Prostate Cancer (13 citations)
• Current Advances in Immunotherapy for Glioblastoma (4 citations)
• Management of the Neck in Well-Differentiated Thyroid Cancer (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Oncology Reports (based on the number of publications) are:

• Maurie Markman (33 papers) absent at the last edition,
• Kim Margolin (18 papers) absent at the last edition,
• Ehab Y. Hanna (17 papers) absent at the last edition,
• Ronald M. Bukowski (16 papers) absent at the last edition,
• Shreyaskumar Patel (15 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Oncology Reports (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (230 papers) published 13 papers at the last edition, 7 more than at the previous edition,
• Memorial Sloan Kettering Cancer Center (93 papers) published 3 papers at the last edition the same number as at the previous edition,
• Cleveland Clinic (72 papers) published 5 papers at the last edition,
• Mayo Clinic (64 papers) published 7 papers at the last edition, 2 more than at the previous edition,
• Harvard University (57 papers) published 5 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.46% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 28.23% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.06% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.52% of all publications and 49.19% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Nursing Education and Research Opportunities

When it comes to nursing education and abreast practice, opportunities abound. The discipline merges with Oncology on various fronts, especially in patient care. Nurses are, in many instances, the primary care providers for cancer patients, being heavily involved in chemotherapy administration, managing side effects, as well as educating and providing emotional support to patients and their families.

It is therefore imperative that nurses and aspiring nurses are equipped with the latest knowledge and skills in Oncology, from understanding the complexities of various cancers to administering of various treatments.

Apart from the hands-on patient care, there are also opportunities for nurses to contribute to Oncology research. With their close interactions with patients, nurses have unique insights and can contribute vastly to areas such as improving quality of life for patients and understanding patient responses to treatments. Many top nursing schools offer research opportunities and some even partner with medical research centers to provide the best possible education and research landscapes for their students.

If you're considering a career in nursing with a focus on Oncology, it's worth considering some of the top 10 best nursing schools in Pennsylvania, many of which offer strong programs and practicum experiences in Oncology, along with opportunities to participate in research and develop expertise in this crucial field.